Physicians Realty Trust (NYSE:DOC) – Equities research analysts at B. Riley lowered their Q1 2018 EPS estimates for shares of Physicians Realty Trust in a report released on Thursday, according to Zacks Investment Research. B. Riley analyst C. Kucera now expects that the real estate investment trust will post earnings per share of $0.27 for the quarter, down from their prior forecast of $0.28. B. Riley currently has a “Buy” rating and a $17.50 price target on the stock. B. Riley also issued estimates for Physicians Realty Trust’s FY2018 earnings at $1.09 EPS, Q1 2019 earnings at $0.29 EPS, Q2 2019 earnings at $0.29 EPS, Q3 2019 earnings at $0.29 EPS and Q4 2019 earnings at $0.29 EPS.
Physicians Realty Trust (NYSE:DOC) last released its quarterly earnings data on Wednesday, February 28th. The real estate investment trust reported $0.27 earnings per share for the quarter, meeting the consensus estimate of $0.27. The firm had revenue of $97.30 million during the quarter, compared to the consensus estimate of $98.56 million. Physicians Realty Trust had a return on equity of 1.63% and a net margin of 11.04%. The firm’s quarterly revenue was up 32.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.27 earnings per share.
DOC has been the subject of a number of other reports. Royal Bank of Canada reiterated a “buy” rating and issued a $21.00 target price on shares of Physicians Realty Trust in a report on Wednesday, November 15th. Zacks Investment Research downgraded shares of Physicians Realty Trust from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. Cantor Fitzgerald reiterated a “buy” rating and issued a $18.00 target price on shares of Physicians Realty Trust in a report on Wednesday, February 28th. SunTrust Banks set a $16.00 target price on shares of Physicians Realty Trust and gave the stock a “hold” rating in a report on Wednesday, February 28th. Finally, Bank of America reduced their target price on shares of Physicians Realty Trust from $19.50 to $18.00 and set a “buy” rating for the company in a report on Thursday, March 8th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company. Physicians Realty Trust presently has an average rating of “Buy” and a consensus target price of $18.64.
Physicians Realty Trust (DOC) traded down $0.03 during mid-day trading on Monday, hitting $15.09. The company had a trading volume of 1,088,681 shares, compared to its average volume of 1,645,634. The company has a market capitalization of $2,740.00, a P/E ratio of 65.61, a P/E/G ratio of 2.98 and a beta of 0.53. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.32 and a quick ratio of 1.32. Physicians Realty Trust has a 12-month low of $14.13 and a 12-month high of $21.85.
A number of hedge funds and other institutional investors have recently modified their holdings of DOC. Nisa Investment Advisors LLC boosted its position in Physicians Realty Trust by 355.1% in the fourth quarter. Nisa Investment Advisors LLC now owns 6,280 shares of the real estate investment trust’s stock valued at $113,000 after buying an additional 4,900 shares during the last quarter. Cypress Wealth Services LLC purchased a new stake in Physicians Realty Trust in the fourth quarter valued at approximately $180,000. Greenwood Capital Associates LLC purchased a new stake in Physicians Realty Trust in the fourth quarter valued at approximately $194,000. Zeke Capital Advisors LLC purchased a new stake in Physicians Realty Trust in the fourth quarter valued at approximately $209,000. Finally, Xact Kapitalforvaltning AB purchased a new stake in Physicians Realty Trust in the fourth quarter valued at approximately $262,000. Hedge funds and other institutional investors own 94.06% of the company’s stock.
In related news, Director Tommy G. Thompson acquired 2,705 shares of the business’s stock in a transaction dated Thursday, December 14th. The shares were purchased at an average price of $18.46 per share, for a total transaction of $49,934.30. Following the completion of the acquisition, the director now directly owns 49,339 shares in the company, valued at approximately $910,797.94. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Tommy G. Thompson bought 13,650 shares of the company’s stock in a transaction that occurred on Tuesday, March 6th. The stock was purchased at an average price of $14.71 per share, for a total transaction of $200,791.50. The disclosure for this purchase can be found here. Corporate insiders own 0.51% of the company’s stock.
Physicians Realty Trust Company Profile
Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.